EXACT THERAPEUTICS AS: PRIMARY INSIDER NOTIFICATION
CFO for hire AS, a company fully owned by Stig Jarle Pettersen, CFO of EXACT Therapeutics AS, has on 23 October 2020 transferred 12,000 shares from its VPS account to the VPS account of Dr. Jean Michel Cossery, Board member of EXACT Therapeutics AS.
The background for this transaction is that Jean Michel Cossery did not have a VPS account at the time of the listing of EXACT Therapeutics, a requirement of the Merkur market. Consequently, the shares were held by CFO for hire AS until a VPS account for Jean Michel Cossery was established.
Following this transaction, Jean Michel Cossery SAS has 12,000 shares in EXACT Therapeutics AS and CFO for hire AS has 30,000 shares in EXACT Therapeutics AS.
About EXACT EXACT-Tx is a clinical stage Anglo-Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.
For more information contact:
Dr Rafiq Hasan, CEO of EXACT-Therapeutics
Rafiq@exact-tx.com
Richard Hayhurst/Janet Joy
Tel +44 7711 821527
richard@rhapr.eu